SCHEMBL31667048

SCHEMBL31667048

COc1ccc(CN2C(=O)c3ccccc3C2Cc2ncccc2Br)cn1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.40
HKDC1 Q2TB90 1/20 0.40
ALDH1A1 P00352 4/20 0.36
SCN9A Q15858 4/20 0.36
KCNH2 Q12809 2/20 0.35
GAA P10253 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MAPT P10636 2/20 0.35
HSD17B10 Q99714 1/20 0.35
PKM P14618 1/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
TSHR P16473 1/20 0.35
CYP11B1 P15538 1/20 0.34
TRPV6 Q9H1D0 1/20 0.34
CSF1R P07333 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31667575 0.87 KDM4E (0.54) KDM4EHKDC1ALDH1A1SCN9AMAPT
SCHEMBL31667164 0.82 MAPT (0.40) KDM4EHKDC1ALDH1A1SCN9AKCNH2
SCHEMBL31667574 0.81 KDM4E (0.40) KDM4EHKDC1ALDH1A1SCN9AKCNH2
SCHEMBL31667711 0.80 ALDH1A1 (0.37) KDM4EHKDC1ALDH1A1SCN9AKCNH2
SCHEMBL31666998 0.80 HPGD (0.36) KDM4EHKDC1ALDH1A1SCN9AKCNH2
SCHEMBL31667142 0.80 ALDH1A1 (0.38) KDM4EALDH1A1SCN9AKCNH2GAA
SCHEMBL31667525 0.79 CACNA1G (0.44) KDM4EHKDC1ALDH1A1GAAHTT
SCHEMBL31667014 0.78 PRMT5 (0.38) ALDH1A1SCN9AKCNH2GAAHTT
SCHEMBL31667097 0.77 ALDH1A1 (0.35) ALDH1A1SCN9AKCNH2GAAHTT
SCHEMBL31667124 0.77 ALDH1A1 (0.35) KDM4EALDH1A1SCN9AKCNH2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF SIRONAX LTD (KY) 2026-03-19 US disclosed
EP-4590674-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd (KY) 2025-07-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF NAMPT, NNMT, SARM1 KDM4E 3382/4885HKDC1 1441/4885ALDH1A1 2719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.